09.23.15
Farmingdale, N.Y.-based Misonix Inc., which makes therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, has added Thomas M. Patton to the its board of directors. Patton will fill the vacancy left by the resignation of Thomas O'Neill in May.
Patton is president and CEO of CAS Medical Systems Inc., a non-invasive patient monitoring medical device company. He previously served as CEO of Wright Medical Group, an orthopedic device company, and as president of Novametrix Medical Systems, a patient monitoring company. From 2003 to 2010, Patton acted as an advisor to the healthcare-focused private equity group of Ferrer Freeman & Company and was the co-founder and CEO of QDx Inc., a start-up company that developed a revolutionary platform for hematology diagnostics beginning in 2003.
Patton received his BA from the College of Holy Cross in Worcester, Mass. After graduating magna cum laude from Georgetown University Law Center, he worked at the law firm of Williams & Connolly in Washington, D.C.
Patton is president and CEO of CAS Medical Systems Inc., a non-invasive patient monitoring medical device company. He previously served as CEO of Wright Medical Group, an orthopedic device company, and as president of Novametrix Medical Systems, a patient monitoring company. From 2003 to 2010, Patton acted as an advisor to the healthcare-focused private equity group of Ferrer Freeman & Company and was the co-founder and CEO of QDx Inc., a start-up company that developed a revolutionary platform for hematology diagnostics beginning in 2003.
Patton received his BA from the College of Holy Cross in Worcester, Mass. After graduating magna cum laude from Georgetown University Law Center, he worked at the law firm of Williams & Connolly in Washington, D.C.
